Licheng Ding
YOU?
Author Swipe
View article: Acute myocardial infarction after inactivated COVID-19 vaccination: a case report and literature review
Acute myocardial infarction after inactivated COVID-19 vaccination: a case report and literature review Open
A number of vaccines have been developed and deployed globally to restrain the spreading of the coronavirus disease 2019 (COVID-19). The adverse effect following vaccination is an important consideration. Acute myocardial infarction (AMI) …
View article: Case Report: A balloon-based technique to remove a pearl-like embolus out of the coronary artery
Case Report: A balloon-based technique to remove a pearl-like embolus out of the coronary artery Open
Coronary embolism is considered a rare non-atherosclerotic etiology of acute myocardial infarction, whereas atrial fibrillation is the main etiology of coronary embolism. We report a rare case of a patient with coronary embolism with a spe…
View article: FXYD domain containing ion transport regulator 5 (FXYD5) silencing promotes cell viability and alleviates inflammatory response in cerulein-induced AR42J cells by blocking JAK2/STAT3 signaling pathway
FXYD domain containing ion transport regulator 5 (FXYD5) silencing promotes cell viability and alleviates inflammatory response in cerulein-induced AR42J cells by blocking JAK2/STAT3 signaling pathway Open
Acute pancreatitis (AP), which causes severe morbidity and mortality, is a heavy burden for people clinically and financially. This study was designed to explore the mechanism of AP and try to find effective therapies against AP. The expre…
View article: Peer Review #2 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.1)"
Peer Review #2 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.1)" Open
Objective: To investigate serum intestinal fatty acid-binding protein (I-FABP) in two groups of patients with different duration of hyperglycemia in a cross-sectional study. Materials and methods:In the present study, a total of 280 indivi…
View article: Peer Review #3 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.1)"
Peer Review #3 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.1)" Open
Objective: To investigate serum intestinal fatty acid-binding protein (I-FABP) in two groups of patients with different duration of hyperglycemia in a cross-sectional study. Materials and methods:In the present study, a total of 280 indivi…
View article: Peer Review #1 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.1)"
Peer Review #1 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.1)" Open
Objective: To investigate serum intestinal fatty acid-binding protein (I-FABP) in two groups of patients with different duration of hyperglycemia in a cross-sectional study. Materials and methods:In the present study, a total of 280 indivi…
View article: Peer Review #2 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.2)"
Peer Review #2 of "Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes (v0.2)" Open
Objective: To investigate serum intestinal fatty acid-binding protein (I-FABP) in two groups of patients with different duration of hyperglycemia in a cross-sectional study. Materials and methods:In the present study, a total of 280 indivi…